dangers of taking glp-1 Exploring the Side Effects Receptor Agonist: To Ensure Its Optimal Positioning Dangers of GLP-1 drugs

Asia-Pacific is projected to grow at an 18.81% CAGR, outpacing other regions due to rapid regulatory approvals and rising middle-class demand

Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells

In addition, the high cost of GLP-1 therapies remains a barrier, especially in markets with limited insurance coverage or constrained healthcare budgets The annual cost of treatment with drugs such as Wegovy or Zepbound can exceed several thousand dollars, which may limit accessibility for patients without comprehensive health coverage

Cancer Sometimes, a dark spot on the lip can be a cancerous growth, particularly melanoma